NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022. Read more about NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022. Read more about NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Read more about Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. Read more about NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016. Read more about Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016.
Getting Complex Therapies to More People: A Vexing Dilemma. Read more about Getting Complex Therapies to More People: A Vexing Dilemma.
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. Read more about NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Read more about T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
